ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares rose 0.8% during mid-day trading on Monday . The company traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares were traded during mid-day trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The stock has a fifty day moving average price of C$6.50 and a 200-day moving average price of C$6.50. The firm has a market capitalization of C$162.08 million and a price-to-earnings ratio of -7.30. The company has a current ratio of 5.06, a quick ratio of 4.29 and a debt-to-equity ratio of 1.70.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Trading Halts Explained
- Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
- Investing in the High PE Growth Stocks
- Super Micro Computer: Turning Risk Into Reward at the Crossroads
- Bank Stocks – Best Bank Stocks to Invest In
- After a Reset Year, Is Moderna Stock Poised for a Comeback?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
